Testing effectiveness (Phase 2)Study completedNCT03758404What this trial is testingGene Therapy for Achromatopsia (CNGA3)Who this might be right forAchromatopsia MeiraGTx UK II Ltd 11
Very early researchTemporarily pausedNCT04041232What this trial is testingPBA Use for Treatment of ATF6-/- PatientsWho this might be right forACHROMATOPSIA 7Achromatopsia Columbia University 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT02599922What this trial is testingSafety and Efficacy Trial of AAV Gene Therapy in Patients With CNGB3 Achromatopsia (A Clarity Clinical Trial)Who this might be right forAchromatopsia Beacon Therapeutics 32
Testing effectiveness (Phase 2)Study completedNCT03001310What this trial is testingGene Therapy for Achromatopsia (CNGB3)Who this might be right forAchromatopsia MeiraGTx UK II Ltd 23
Not applicableLooking for participantsNCT07085533What this trial is testingNatural History Study of Inherited Retinal DiseasesWho this might be right forRetinal DystrophiesColor Vision DefectsVision Disorders+7 more Zhongmou Therapeutics 200
Not applicableEnded earlyNCT03278873What this trial is testingLong-Term Follow-Up Gene Therapy Study for Achromatopsia CNGB3 and CNGA3Who this might be right forAchromatopsia MeiraGTx UK II Ltd 34
Not applicableLooking for participantsNCT02435940What this trial is testingInherited Retinal Degenerative Disease RegistryWho this might be right forEye Diseases HereditaryRetinal DiseaseAchromatopsia+25 more Foundation Fighting Blindness 20,000
Testing effectiveness (Phase 2)Study completedNCT01648452What this trial is testingCNTF Implants for CNGB3 AchromatopsiaWho this might be right forEye DiseaseAchromatopsia National Eye Institute (NEI) 5
Not applicableStudy completedNCT04124185What this trial is testingNatural History Study for AchromatopsiaWho this might be right forAchromatopsia MeiraGTx UK II Ltd 85
Not applicableStudy completedNCT01846052What this trial is testingClinical and Genetic Characterization of Individuals With AchromatopsiaWho this might be right forAchromatopsia Beacon Therapeutics 56
Not applicableLooking for participantsNCT06491615What this trial is testingNational Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic DiseasesWho this might be right forInherited Ophthalmic DiseasesHypopigmentation DisorderCorneal Dystrophy+4 more National Eye Institute (NEI) 1,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT02610582What this trial is testingSafety and Efficacy of rAAV.hCNGA3 Gene Therapy in Patients With CNGA3-linked AchromatopsiaWho this might be right forAchromatopsia STZ eyetrial 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT02935517What this trial is testingSafety and Efficacy Trial of AAV Gene Therapy in Patients With CNGA3 Achromatopsia (A Clarity Clinical Trial)Who this might be right forAchromatopsia Beacon Therapeutics 24